INFASURF

This brand name is authorized in Singapore, Tunisia, Turkey, United States

Active ingredients

The drug INFASURF contains one active pharmaceutical ingredient (API):

1 Beractant UNII Q4K217VGA9 - CALFACTANT

Read about Beractant

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INFASURF Suspension	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R07AA02	Natural phospholipids	R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AA Lung surfactants
Discover more medicines within R07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: SG	Health Sciences Authority	Identifier(s): 14333P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12673011H, 12673012H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699738770785, 8699738770822
Country: US	FDA, National Drug Code	Identifier(s): 61938-456